US88338N2062 - Common Stock
THERAPEUTICSMD INC
NASDAQ:TXMD (5/1/2024, 3:33:45 PM)
1.885
+0.01 (+0.27%)
TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employees. The company went IPO on 2001-01-31. The firm is focused on developing and commercializing products exclusively for women. The company is engaged in conducting business by out-licensing its products and collecting royalties, after granting a license to commercialize the Company's IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands in the United States and its possessions and territories and assigning the Company’s exclusive license to commercialize ANNOVERA in the United States and its possessions and territories to Mayne Pharma. ANNOVERA is a one-year (13 cycles) ring-shaped contraceptive vaginal system (CVS)). ANNOVERA, which is made with a silicone elastomer, contains segesterone acetate, a 19-nor progesterone derivative also known as Nestorone (SA) and ethinyl estradiol (EE). Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.
THERAPEUTICSMD INC
951 Yamato Road, Suite 220
Boca Raton FLORIDA 33431
P: 15619611900
CEO: Robert G. Finizio
Employees: 1
Website: https://www.therapeuticsmd.com/
TherapeuticsMD (TXMD) said it is exploring strategic alternatives for the company, including a possible business combination or asset sale. Read more here.
Here you can normally see the latest stock twits on TXMD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: